Parabilis Medicines, Inc. (PBLS)
NASDAQ: PBLS · Real-Time Price · USD
40.42
-0.33 (-0.81%)
At close: Sep 4, 2026, 4:00 PM EDT
39.31
-1.11 (-2.75%)
After-hours: Sep 4, 2026, 7:45 PM EDT
Parabilis Medicines Employees
Parabilis Medicines had 145 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
145
Change
n/a
Growth
n/a
Revenue / Employee
$1,021
Profits / Employee
-$1,597,703
Market Cap
4.99B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 145 | 0 | - |
| Dec 31, 2025 | 145 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| ACADIA Pharmaceuticals | 798 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Dyne Therapeutics | 289 |
| Celcuity | 155 |
| Edgewise Therapeutics | 127 |
| Definium Therapeutics | 106 |
PBLS News
- 6 days ago - Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - GlobeNewsWire
- 13 days ago - Parabilis Medicines appoints Craig Tendler to board of directors - TheFly
- 13 days ago - Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D. - GlobeNewsWire
- 21 days ago - Parabilis Medicines reports Q2 EPS ($2.32), consensus (24c) - TheFly
- 25 days ago - Parabilis Medicines Slides: Corporate presentation - Filings
- 25 days ago - Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 25 days ago - Parabilis Medicines Earnings release: Q2 2026 - Filings
- 25 days ago - Parabilis Medicines Quarterly report: Q2 2026 - Filings